Cargando…

Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO(2) study

The klotho and fibroblast growth factor 23 (FGF-23) pathway is implicated in cardiovascular pathophysiology. This substudy aimed to assess the changes in klotho and FGF-23 levels 1-month after dapagliflozin in patients with stable heart failure and reduced ejection fraction (HFrEF). The study includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mora-Fernández, Carmen, Pérez, Adora, Mollar, Anna, Palau, Patricia, Amiguet, Martina, de la Espriella, Rafael, Sanchis, Juan, Górriz, Jose Luis, Soler, María José, Navarro-González, Juan F., Núñez, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515719/ https://www.ncbi.nlm.nih.gov/pubmed/37745119 http://dx.doi.org/10.3389/fcvm.2023.1242108

Ejemplares similares

Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction
por: Amiguet, Martina, et al.
Publicado: (2023)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Right Ventricular Dysfunction Staging System for Mortality Risk Stratification in Heart Failure with Preserved Ejection Fraction
por: Santas, Enrique, et al.
Publicado: (2020)

FGF23 Actions on Target Tissues—With and Without Klotho
por: Richter, Beatrice, et al.
Publicado: (2018)

The effect of nephrectomy on Klotho, FGF-23 and bone metabolism
por: Kakareko, Katarzyna, et al.
Publicado: (2017)

FGF-23, Klotho and Vitamin D Levels in Scleroderma
por: AHMADI, Ravan, et al.
Publicado: (2017)

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus
por: Donate-Correa, Javier, et al.
Publicado: (2019)

Sex‐Related Differences in Mortality Following Admission for Acute Heart Failure Across the Left Ventricular Ejection Fraction Spectrum
por: Santas, Enrique, et al.
Publicado: (2021)

Estimated Population Prevalence of Heart Failure with Reduced Ejection Fraction in Spain, According to DAPA-HF Study Criteria
por: Camps-Vilaró, Anna, et al.
Publicado: (2020)

Is there a role in acute kidney injury for FGF23 and Klotho?
por: Mattinzoli, Deborah, et al.
Publicado: (2023)

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF
por: Butt, Jawad H., et al.
Publicado: (2021)

Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
por: Miñana, Gema, et al.
Publicado: (2022)

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
por: Jackson, Alice M., et al.
Publicado: (2020)

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2022)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
por: Lindberg, Karolina, et al.
Publicado: (2013)

Editorial: Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
por: Erben, Reinhold G.
Publicado: (2019)

Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF
por: Adamson, Carly, et al.
Publicado: (2022)

Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
por: Muñoz-Castañeda, Juan Rafael, et al.
Publicado: (2020)

Short‐term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial‐IRON trial
por: Santas, Enrique, et al.
Publicado: (2020)

Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
por: Six, Isabelle, et al.
Publicado: (2014)

Molecular Mechanisms Underlying Accelerated Aging by Defects in the FGF23-Klotho System
por: Kuro-o, Makoto
Publicado: (2018)

Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation
por: Tartaglione, Lida, et al.
Publicado: (2017)

The Role of Alterations in Alpha-Klotho and FGF-23 in Kidney Transplantation and Kidney Donation
por: Gupta, Meera, et al.
Publicado: (2022)

Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study
por: Núñez, Julio, et al.
Publicado: (2016)

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2021)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023)

Short‐Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial‐IRON Trial
por: del Canto, Irene, et al.
Publicado: (2022)

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2020)

FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

FGF-23–Klotho signaling stimulates proliferation and prevents vitamin D–induced apoptosis
por: Medici, Damian, et al.
Publicado: (2008)

Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
por: Nowak, Albina, et al.
Publicado: (2014)

Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis
por: Cano, Francisco J., et al.
Publicado: (2014)

αKlotho is a Non-Enzymatic Molecular Scaffold for FGF23 Hormone Signaling
por: Chen, Gaozhi, et al.
Publicado: (2018)

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2020)

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF
por: Dewan, Pooja, et al.
Publicado: (2021)

Central role of the proximal tubular αKlotho/FGF receptor complex in FGF23-regulated phosphate and vitamin D metabolism
por: Takeshita, Ai, et al.
Publicado: (2018)

FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients
por: Pasaoglu, Ozge Tugce, et al.
Publicado: (2021)

Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho axis
por: Wei, Xu, et al.
Publicado: (2021)

Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and Klotho
por: Gayan‐Ramirez, Ghislaine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dht30iqd0jiag6rhrdd78kmuff